Solazyme stock rocks after Q2 results, binding Sasol offtake deal
Bioenergy’s #1 company surges on the exchanges after big Sasol, AkzoNobel partnership announcements. In California, Solazyme announced a Q2 loss of $25.8M, compared to a Q2 2012 loss of $19.2M, on revenues of $11.2M, down from $13.2M for Q2 2012, as government funded revenues declined as expected. Excluding the government sector, sales jumped 28% year […]














